Paper Details

  1. Home
  2. Paper Details

Optimisation of treatments for oral <i>Neisseria gonorrhoeae</i> infection: Pharmacokinetics Study (STI-PK project) - study protocol for non-randomised clinical trial.

Author: ChowEric P F, FairleyChristopher K, HammoudMohamed A, HockingJane S, KongFabian Y S, LandersdorferCornelia B, LatchNgaire, LewisDavid A, LimShueh H, ParkerSuzanne L, RobertsJason A, UnemoMagnus, WallisSteven C, WilliamsonDeborah A, YapTami

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Oropharyngeal *Neisseria gonorrhoeae* infections are associated with greater treatment failure and drive transmission to other sites. Gonococcal resistance is increasing, highlighting the need for optimal treatments and accurate pharmacokinetic data from the oral cavity/oropharynx.
Paper Details　
Original Abstract of the Article :
Label="INTRODUCTION"> <i>Neisseria gonorrhoeae</i> infections are common and incidence increasing. Oropharyngeal infections are associated with greater treatment failure compared with other sites and drive transmission to anogenital sites through saliva. Gonococcal resistance is increasing and new t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660608/

データ提供：米国国立医学図書館（NLM）

Optimizing Treatment for Oral Neisseria gonorrhoeae Infection: A Pharmacokinetic Study

The fight against sexually transmitted infections (STIs) requires continuous research and development. This study proposes a non-randomized clinical trial to investigate the pharmacokinetics of various treatments for oral Neisseria gonorrhoeae infection. The research aims to optimize current and emerging treatments, addressing the challenge of increasing drug resistance. By focusing on pharmacokinetic data from the oral cavity/oropharynx, the study seeks to improve the efficacy and effectiveness of treatments for this challenging infection.

Seeking a Solution: Optimizing Treatment for Oral Gonorrhea

This study emphasizes the need for effective and targeted treatments for oral gonorrhea. It highlights the importance of tailoring drug regimens to specific sites of infection, recognizing the unique challenges posed by oral infections. The research underscores the critical role of pharmacokinetic studies in refining treatment strategies for STIs.

A New Approach: Pharmacokinetic Insights for Optimized Treatment

The study's focus on pharmacokinetics provides a valuable tool for optimizing treatment for oral gonorrhea. Understanding how drugs are absorbed, distributed, metabolized, and eliminated within the body can guide the development of more effective treatment regimens. This research is like a beacon of hope, illuminating the path towards better and more targeted treatments for this challenging infection.

Dr. Camel's Conclusion

The proposed pharmacokinetic study for oral gonorrhea is a testament to the dedication of researchers in seeking more effective treatments for challenging infections. By understanding the nuances of drug distribution in the oral cavity, researchers can develop more tailored and effective treatment regimens. It's like a camel caravan navigating the desert of drug development, seeking the most efficient and reliable routes to deliver optimal treatment for patients.

Date :
  1. Date Completed 2022-11-15
  2. Date Revised 2022-12-22
Further Info :

Pubmed ID

36368750

DOI: Digital Object Identifier

PMC9660608

Related Literature

Article Analysis
・Side Effects of azithromycin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.